1. Introduction {#sec1}
===============

Cirrhosis is the advanced stage of a liver condition due to a chronic inflammatory and fibrosing prolonged evolving process. Cirrhotic patients are more susceptible to bacterial infection (BI) because of humeral and cell-mediated immunodeficiency, splanchnic ganglia colonization, bacterial translocation phenomena, and ventilatory disorders related to encephalopathy and ascites \[[@B1], [@B2]\]. BI is diagnosed in 30 to 50% of admitted cirrhotic versus 5 to 7% in noncirrhotic patients \[[@B3]\]. The diagnosis of BI in patients with cirrhosis is made difficult by some clinical and biological abnormalities commonly observed in those patients such as liver dysfunction, inflammation, chronic hypersplenism, abdominal distension, and neurological disorders in addition to the frequent use of betablockers. Despite the great improvement of BI management in cirrhotics, the mortality is still high. An early diagnosis and treatment of this condition, using biomarkers such as procalcitonin (PCT) and C-reactive protein (CRP), can contribute to reduce this mortality. This work is aimed at evaluating and comparing diagnosis and prognosis performance of CRP and PCT during BI in patients admitted for decompensated cirrhosis.

2. Methods {#sec2}
==========

This 14-month observational retrospective study was conducted in the Hepato-gastroenterology Department of the Charles Nicolle University Hospital of Tunis from 01 September 2015 to 30 October 2016. We included patients admitted for decompensate cirrhosis. Cirrhosis was diagnosed according to histological and/or clinical, biological, and ultrasound findings suggesting portal hypertension and hepatocellular insufficiency. Decompensated cirrhosis was defined by the presence of ascites, jaundice, variceal hemorrhage, or hepatic encephalopathy. Patients not included in the study were those who were receiving intravenous antibiotics and those who were suffering from a systemic disease or a cancer including hepatocellular carcinoma. CRP and PCT are part of the routine biological sample performed at admission; we did not have to get patients\' consent. The following severity and prognostic scores were used in our study: APACHE II score \[[@B4]\], Child-Turcotte-Pugh (CP) criteria \[[@B5]\], Model for End-Stage Liver Disease score (MELD) \[[@B6]\], CLIF-sequential organ failure assessment score (CLIF-SOFA), and Acute-on-chronic liver failure (ACLF) \[[@B7]\]. Blood samples for biological marker analysis as well as microbiological samples were obtained on admission. Serum CRP levels were measured using direct immunoturbidimetry on the Architect C 8000 Chemistry System (Abbott Diagnostics, USA). Enzyme-linked fluorescent immunoassay (ELFA) on mini-VIDAS (bioMérieux, France) was used for PCT tests. The patients were divided into a BI group and a non-BI (NBI) group. Dichotomous variables were expressed as percentages and continuous variables as mean ± standard deviation. Statistical comparisons were performed using, respectively, Student\'s *t*-test and *χ*^2^. Analysis of receiver operating characteristic (ROC) curves was used to determine diagnostic accuracy, sensitivity, and specificity and the Youden index to determine suggested cutoff. All analyses were conducted by SPSS 20.0 (SPSS Inc., Chicago, IL, USA). A *p* value of \<0.05 was considered significant. Three-month mortality risk factors were determined by the application of multivariate logistic regression analysis. The authors state the absence of conflict of interest.

3. Results {#sec3}
==========

Ninety-two patients were included with a sex ratio of 0.96 and a mean age of 63 ± 13 years (19-91). Mean follow-up time was 4.5 ± 4 years (3 months-26 years). Fifty-seven patients (61%) were CP class B and 32% class C. Hepatitis C was the most common etiology of cirrhosis (42%). They were mainly admitted for edemato-ascitic decompensation and the main source of infection was pulmonary tract infection (62%) and spontaneous bacterial peritonitis (23%). Baseline characteristics, cirrhosis etiologies, causes for admission, infection sources, and severity scores are summarized in [Table 1](#tab1){ref-type="table"}. Distributions of sex, age, and comorbidities were similar between the two groups ([Table 2](#tab2){ref-type="table"}). BI group had significantly higher encephalopathy rate (*p* = 0.005), higher body temperature (*p* = 0.008), higher heart rate (*p* = 0.025), higher total serum bilirubin level (*p* = 0.021), higher international normalized ratio (*p* = 0.005), lower prothrombin time (*p* = 0.005), and higher MELD score (*p* \< 0.01). Mean serum levels of CRP (*p* \< 0.001), PCT (*p* \< 0.001), and white blood cells (WBC) (*p* = 0.002) were significantly higher in the BI group than in the NBI group ([Table 2](#tab2){ref-type="table"}). The results of the logistic regression analysis showed that only MELD score \> 15, encephalopathy, and PCT ≥ 0.5were significantly correlated to BI ([Table 3](#tab3){ref-type="table"}). We evaluated the effectiveness of WBC, PCT, and CRP measurements in predicting infection in decompensated cirrhosis using the assessment of ROC curves. The area under the curve (AUC), sensitivity, specificity, positive and negative predictive values, and suggested cutoff values for each marker are summarized in [Table 4](#tab4){ref-type="table"}. ROC analysis of CRP serum level showed the slightly higher AUC (0.745). PCT was more specific (96.6% vs. 75%) whereas CRP was more sensitive (70 vs. 45%).

3.1. Three-Month Mortality {#sec3.1}
--------------------------

Three-month mortality rate was 27%. Patients in the BI group had higher 3-month mortality rate (34% vs. 3%, *p* = 0.008) than those in the NBI group. However, multivariate risk factor analysis indicated that BI was not an independent 3-month mortality risk factor ([Table 5](#tab5){ref-type="table"}). PCT serum level was significantly associated with 3-month mortality (*p* \< 0.001). ROC analysis of PCT serum level showed the AUC of 0.735 (CI 95%: 0.576-0.895). Suggested cutoff was 0.5 ng/mL; sensitivity, specificity, positive predictive value, and negative predictive value were, respectively, 66.7%, 77.6%, 59%, and 82% ([Figure 1](#fig1){ref-type="fig"}). In the BI group, deceased patients were more often Child-Pugh class C and had lower temperature on admission, higher Child-Pugh score, higher leukocyte, neutrophil, and platelet counts, lower prothrombin time, and higher serum CRP, PCT, and creatinine levels ([Table 6](#tab6){ref-type="table"}). In multivariate logistic regression mode, CP class C, lower temperature on admission, higher CP score, and higher platelet count were retained as predictors\' parameters for three-month mortality ([Table 7](#tab7){ref-type="table"}).

4. Discussion {#sec4}
=============

In our study, the high rate of BI among patients with decompensated cirrhosis can be explained by the advanced liver failure observed in these patients. Our results showed that PCT and CRP serum levels were significantly higher in the BI group, and thus, these markers were useful in the diagnosis of BI in decompensated cirrhosis. Although they are mainly produced by the liver, hepatic insufficiency does not affect their diagnostic accuracy \[[@B8]\]. That is explained by a maintained hepatic production \[[@B9]--[@B11]\] and/or an extrahepatic production \[[@B12]--[@B15]\] of those two biomarkers during cirrhosis. On the other side, WBC count is deeply influenced by hypersplenism even if their production may be maintained. That can explain the less BI diagnosis accuracy of WBC observed in our study. Several studies have shown the reliability of PCT and CRP for the diagnosis of infection during cirrhosis with important AUC. In a recent meta-analysis including 1144 patients with liver cirrhosis, AUC for PCT and CRP was, respectively, 0.92 (95% CI: 0.89-0.94) and 0.87 (95% Cl: 0.84-0.90) \[[@B16]\]. This is probably due to differences in demographic characteristics and cirrhosis severity observed in our population. The cutoffs used are also different from ours. In the present study, diagnostic accuracy of CRP and PCT was comparable but it is still relatively low. That is why we think that PCT and CRP cannot be used alone to either confirm or exclude BI diagnosis. We found that, for the diagnosis of BI, CRP was more sensitive (70% vs. 45%) while PCT was more specific (96.9% vs. 75%). Similar results were reported by Lin et al.: CRP sensitivity was higher (87% vs. 79%) while PCT was more specific (89% vs. 85%) \[[@B16]\]. In addition, the CRP had a more discriminative value in the Papp study \[[@B17]\]. In order to enhance the diagnostic performance of CRP and PCT, the use of an algorithm that integrates clinical data with PCT or CRP can be helpful. In addition, it may be interesting to study the usefulness of an algorithm combing CRP and PCT.

4.1. Mortality {#sec4.1}
--------------

We have reconfirmed the gravity of BI in cirrhotics as already attested \[[@B18]\]. Three-month mortality was twelve times higher in infected patients compared to noninfected patients (34% vs. 3%, *p* = 0.08). However, multivariate risk factor analysis indicated that BI was not an independent 3-month mortality risk factor. Lazzarotto et al. did not find any association between infection at admission and death before the seventh day of hospitalization \[[@B19]\]. In Khot et al. study, sepsis was not objectively an independent predictor of mortality \[[@B20]\]. In our study, only serum PCT level was significantly related to 3-month mortality. The relationship between PCT and CRP levels and mortality reported in previous studies was contradictory \[[@B19], [@B21]--[@B23]\]. However, in the BI group, PCT and CRP did not show any prognostic value. That can be explained by the high severity of cirrhosis in the NBI group. In fact, the CP score influenced death.

Our study has limitations. It is a monocentric study with a relatively small number of patients. In addition, PCT measurement was performed on admission regardless of the presence or the absence of infection.

5. Conclusion {#sec5}
=============

Regarding BI in patients with decompensated cirrhosis, CRP maintains efficiency slightly higher than that of the PCT without being discriminative. However, no prognostic value has been established for these markers. In order to improve the diagnosis and reliability of prognosis, it may be interesting to combine them with each other or with other biological and/or clinical parameters.
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###### 

Baseline characteristics of patients.

  ----------------------------------- -----------------
  *Number of patients*                92
  *Mean age, years*                   63 ± 13 (19-91)
  *Male,n*                            45
  *Female,n*                          47
  *Cirrhosis etiology,n(%)*           
  Hepatitis C                         39 (42)
  Hepatitis B                         9 (10)
  Autoimmune hepatitis                7 (8)
  Primary biliary cirrhosis           8 (9)
  Alcohol                             3 (4)
  Nonalcoholic steatohepatitis        7 (8)
  Cryptogenic                         13 (14)
  Others                              4 (5)
  *Causes for admission,n(%)*         
  Edemato-ascitic decompensation      46 (50)
  Hepatic encephalopathy              23 (25)
  Gastro-intestinal bleeding          14 (15)
  Fever                               14 (15)
  Others                              9 (10)
  *Infection source,n(%)*             
  Pulmonary tract infection           37 (62)
  Urinary tract infection             12 (20)
  Spontaneous bacterial peritonitis   14 (23)
  Skin infection                      5 (8)
  Multiple sites                      6 (10)
  Bacteremia                          9 (14)
  Isolated                            3 (5)
  Associated to another source        6 (10)
  *Severity scores*                   
  Child-Pugh class (%)                
  A                                   7
  B                                   61
  C                                   32
  *Child-Pugh, mean*                  10 ± 2 (6--15)
  *ACLF (%)*                          
  Grade 1                             33
  Grade 2                             32
  Grade 3                             35
  *MELD score, mean*                  18 ± 7 (8-35)
  *APACHE II score, mean*             20 ± 5 (12-34)
  ----------------------------------- -----------------

MELD: Model for End-Stage Liver Disease; APACHE II: Acute Physiology and Chronic Health Disease Classification System II; ACLF: Acute-on-chronic liver failure.

###### 

Clinical and laboratory variables associated with infection on admission.

  ------------------------------------------------------------------------------------------------------------
                                      Bacterial infection group\   Nonbacterial infection group\   *p* value
                                      *n* = 60                     *n* = 32                        
  ----------------------------------- ---------------------------- ------------------------------- -----------
  Age (yr)                            60 ± 12                      64 ± 15                         0.509

  Male/female                         30/30                        15/17                           0.775

  Medical history                                                                                  

   Diabetes mellitus                  38%                          44%                             0.614

   Hypertension                       28%                          41%                             0.231

   Tabagism                           28%                          19%                             0.350

   Alcoholism                         15%                          13%                             0.786

  Child-Pugh (class)                                                                               

   A                                  1%                           6%                              0.123

   B                                  28%                          44%                             0.256

   C                                  70%                          50%                             0.456

   MELD score                         20 ± 7                       15 ± 5                          \<.001

   APACHE II score                    13 ± 8                       15 ± 6                          0.855

   CLIF-SOFA score                    15 ± 6                       16 ± 6                          0.757

  ACLF                                                                                             

   Grade 1                            32%                          38%                             0.573

   Grade 2                            33%                          28%                             0.609

   Grade 3                            34%                          34%                             0.952

  Duration of stay (d)                12 ± 8                       12 ± 6                          0.766

  3-month mortality                   34%                          3%                              0.008

  Vital signs                                                                                      

   Body temperature (°C)              38 ± 0.7                     37 ± 0.5                        0.008

   Heart rate (beats/min)             97 ± 15                      85 ± 18                         0.025

   Respiratory rate (breaths/min)     21 ± 4                       20 ± 5                          0.189

   Systolic blood pressure (mm Hg)    108 ± 21                     111 ± 20                        0.393

   Diastolic blood pressure (mm Hg)   62 ± 13                      66 ± 10                         0.193

   Encephalopathy                     72%                          37%                             0.005

   Ascite                             85%                          84%                             0.647

   WBCs (cells/lL)                    8750 ± 5005                  5672 ± 2734                     0.002

   Neutrophil (cells/lL)              6430 ± 4456                  3668 ± 2151                     0.001

   Platelet (cells/lL)                105056 ± 80901               91000 ± 42063                   0.361

   Serum BUN (mmol/L)                 8.8 ± 5.2                    7.4 ± 5.9                       0.282

   Serum creatinine (*μ*mol/L)        116 ± 101                    90 ± 51                         0.167

   AST (IU/L)                         78 ± 106                     56 ± 38                         0.350

   ALT (IU/L)                         43 ± 55                      40 ± 55                         0.803

   Total bilirubin (mg/L)             102 ± 137                    43 ± 45                         0.021

   PT (%)                             48 ± 18                      58 ± 16                         0.007

   INR                                1.91 ± 0.64                  1.55 ± 0.36                     0.005

   Albumin (g/L)                      25 ± 5                       26 ± 5                          0.579

   Serum sodium                       132 ± 5                      134 ± 4                         0.177

   CRP (mg/L)                         46 ± 44.5                    19.61 ± 24.95                   \<.001

   PCT (ng/mL)                        1.84 ± 4.07                  0.20 ± 0.48                     \<.001
  ------------------------------------------------------------------------------------------------------------

ALT: alanine aminotransferase; AST: aspartate aminotransferase; CRP: C-reactive protein; PCT: procalcitonin; INR: international normalized ratio; WBC: white blood cell; PT: prothrombin time; MELD: Model for End-Stage Liver Disease; APACHE II: Acute Physiology and Chronic Health Disease Classification System II; BUR: blood urea nitrogen; CLIF-SOFA: chronic liver failure-sequential organ failure assessment; ACLF: Acute-on-chronic liver failure.

###### 

Univariate and multivariate analysis of factors associated with bacterial infection.

                              Bacterial infection diagnosis   
  --------------------------- ------------------------------- -------
  Age \> 60 years             0.609                           0.285
  Gender                      0.775                           0.399
  Tabagism                    0.35                            0.376
  Alcoholism                  0.786                           0.076
  Diabetes mellitus           0.614                           0.75
  Hypertension                0.231                           0.535
  Duration of cirrhosis       0.170                           0.473
  Length of hospitalization   0.291                           0.843
  Child-Pugh score            0.311                           0.199
  MELD score \> 15            0.001                           0.022
  Ascite                      0.937                           0.744
  Encephalopathy              0.001                           0.021
  WBC ≥ 6635 cells/lL         0.005                           0.22
  CRP ≥ 20 mg/L               0.000                           0.184
  PCT ≥ 0.5 ng/mL             0.000                           0.009

WBC: white blood cells; CRP: C-reactive protein; PCT: procalcitonin; MELD: Model for End-Stage Liver Disease.

###### 

The results of ROC curve analysis for bacterial infection diagnosis.

          AUC (95% CI)                  *p*          Suggested cutoff   Sensitivity (%)   Specificity (%)   PPV (%)    NPV (%)
  ------- ----------------------------- ------------ ------------------ ----------------- ----------------- ---------- ---------
  *WBC*   0.694 (IC 95%: 0.585-0.803)   **0.002**    **6635**           **65**            **65.5**          **78**     **50**
  *CRP*   0.745 (IC 95%: 0.635-0.855)   **\<.001**   **20**             **70**            **75**            **84**     **57**
  *PCT*   0.741 (IC 95%: 0.639-0.843)   **\<.001**   **0.5**            **45**            **96.6**          **97.5**   **59**

WBC: white blood cells. CRP: C-reactive protein; PCT: procalcitonin; PPV: positive predictive value; NPV: negative predictive value.

###### 

Univariate and multivariate analysis of factors associated with 3-month mortality in admitted patients with decompensated liver cirrhosis.

                       Univariate analysis   Multivariate analysis
  -------------------- --------------------- -----------------------
  Child-Pugh (class)   0.006                 0.007
  Encephalopathy       0.013                 0.005
  Infection            0.001                 0.485
  Heart rate           0.005                 0.092
  Temperature          0.055                 0.547
  WBC                  0.001                 0.331
  Neutrophil count     \<0.001               0.155
  Platelets            \<0.001               0.490
  PT %                 0.029                 0.321
  INR                  0.036                 0.962
  CRP                  0.001                 0.053
  PCT                  0.018                 \<0.001
  Serum creatinine     0.014                 \<0.001
  AST                  0.095                 \<0.001
  Child-Pugh (score)   0.009                 0.006
  MELD                 \<0.001               0.091

WBC: white blood cells; INR: international normalized ratio; CRP: C-reactive protein; PT: prothrombin time; PCT: procalcitonin; AST: aspartate aminotransferase; MELD: Model for End-Stage Liver Disease.

###### 

Clinical and laboratory variables associated with 3-month mortality in the BI group.

                                Surviving       Deceased         *p* value
  ----------------------------- --------------- ---------------- -----------
  Sex                           16/21           9/14             0.184
  Child-Pugh (class)                                             
   A                            0%              3%               0.427
   B                            4%              43%              0.001
   C                            96%             54%              0.001
  Child-Pugh score              10 ± 2          11 ± 1           0.004
  Respiratory rate              21 ± 3          21 ± 4           0.720
  Temperature                   38 ± 0.8        37 ± 0.6         0.004
  WBC (cells/lL)                7632 ± 3651     10549 ± 6314     0.027
  Neutrophil count (cells/lL)   5369 ± 3049     8137 ± 5771      0.018
  Platelets (cells/lL)          83659 ± 66387   139478 ± 91280   0.008
  PT (%)                        51 ± 19         41 ± 13          0.031
  CRP (mg/L)                    37 ± 29         61 ± 60          0.041
  PCT (ng/mL)                   1.21 ± 2 ± 88   2.84 ± 5.39      0.131
  Creatinine (*μ*mol/L)         96 ± 63         150 ± 139        0.045
  AST (IU/L)                    63 ± 44         91 ± 162         0.396
  MELD                          18 ± 7          23 ± 6           0.005

PT: prothrombin time; WBC: white blood cells; CRP: C-reactive protein; PCT: procalcitonin; AST: aspartate aminotransferase; MELD: Model for End-Stage Liver Disease.

###### 

Univariate and multivariate analysis of factors associated with 3-month mortality in the BI group.

  Variable             Univariate analysis   Multivariate analysis
  -------------------- --------------------- -----------------------
  Sex                  0.184                 0.900
  Child-Pugh (class)                         
   B                   \<0.001               0.887
   C                   \<0.001               \<0.001
  Child-Pugh (score)   0.004                 0.627
  Respiratory rate     0.720                 0.111
  Temperature          0.004                 0.01
  WBC                  0.027                 0.131
  Neutrophil count     0.018                 0.075
  Platelets            0.008                 0.018
  Prothrombin time     0.031                 0.874
  CRP                  0.041                 0.225
  PCT                  0.131                 0.318
  Serum creatinine     0.045                 0.197
  AST                  0.396                 0.300
  MELD score           0.005                 0.411

WBC: white blood cells; CRP: C-reactive protein; PCT: procalcitonin; AST: aspartate aminotransferase; MELD: Model for End-Stage Liver Disease.

[^1]: Academic Editor: Hauke S. Heinzow
